U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

    {{facet.count}}
    {{facet.count}}

Showing 301 - 310 of 338 results

structurally diverse
Status:
Investigational
Source:
INN:fencabtagene autoleucel [INN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
USAN:LAPULEUCEL-T [USAN]
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
Investigational
Source:
NCT03563144: Phase 2 Interventional Withdrawn Metastatic Pancreatic Cancer
(2018)
Source URL:

Class:
STRUCTURALLY DIVERSE

structurally diverse
Status:
US Approved Allergenic Extract (1972)
First marketed in 1921
Source:
Oil of Theobroma U.S.P.
Source URL:

Class:
STRUCTURALLY DIVERSE

Concept
Status:
Investigational
Source:
NCT02473731: Phase 1 Interventional Completed Squamous Cell Carcinoma of the Head and Neck
(2015)
Source URL:

Class:
CONCEPT

Showing 301 - 310 of 338 results